U.S. flag

An official website of the United States government

NM_001358921.2(COQ2):c.261G>A (p.Trp87Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 14, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003669358.2

Allele description [Variation Report for NM_001358921.2(COQ2):c.261G>A (p.Trp87Ter)]

NM_001358921.2(COQ2):c.261G>A (p.Trp87Ter)

Gene:
COQ2:coenzyme Q2, polyprenyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q21.23
Genomic location:
Preferred name:
NM_001358921.2(COQ2):c.261G>A (p.Trp87Ter)
HGVS:
  • NC_000004.12:g.83279107C>T
  • NG_015825.1:g.10808G>A
  • NM_001358921.2:c.261G>AMANE SELECT
  • NM_015697.9:c.411G>A
  • NP_001345850.1:p.Trp87Ter
  • NP_056512.5:p.Trp137Ter
  • NC_000004.11:g.84200260C>T
Protein change:
W137*
Molecular consequence:
  • NM_001358921.2:c.261G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_015697.9:c.411G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004391882Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 14, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.

Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, Dimauro S, Hirano M.

Am J Hum Genet. 2006 Feb;78(2):345-9. Epub 2005 Dec 22.

PubMed [citation]
PMID:
16400613
PMCID:
PMC1380241

Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis.

López-Martín JM, Salviati L, Trevisson E, Montini G, DiMauro S, Quinzii C, Hirano M, Rodriguez-Hernandez A, Cordero MD, Sánchez-Alcázar JA, Santos-Ocaña C, Navas P.

Hum Mol Genet. 2007 May 1;16(9):1091-7. Epub 2007 Mar 20.

PubMed [citation]
PMID:
17374725
PMCID:
PMC4345105
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004391882.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Trp137*) in the COQ2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COQ2 are known to be pathogenic (PMID: 16400613, 17374725). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COQ2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2444449). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024